Cargando…
The Superiority of Zoledronic Acid Over Risedronate for Paget’s Disease: A 16-Year Experience at a Single Institution
Introduction Bisphosphonates are considered to be the treatment of choice for patients with active Paget’s disease. The aim of this study was to record and assess the therapeutic effect in response to a single intravenous infusion of 5mg zoledronic acid or oral risedronate. Methods A retrospective o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873448/ https://www.ncbi.nlm.nih.gov/pubmed/36712714 http://dx.doi.org/10.7759/cureus.32923 |